造血干细胞移植的早期和晚期并发症
Malgorzata Mikulska1, Francesca Gualandi2, Paola Anserini3
1Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Handbook of clinical neurology
|August 7, 2024
概括
针对多发性硬化症 (MS) 的自身干细胞移植 (ASCT) 可以导致早期感染和非传染性问题,以及晚期自身免疫性疾病和生育问题. 仔细监测和咨询对于管理这些不良影响至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 自主干细胞移植 (ASCT) 是对多发性硬化症 (MS) 的新兴治疗方法.
- 了解ASCT的不良影响对于患者管理至关重要.
- 早期和晚期并发症需要不同的监测和干预策略.
研究的目的:
- 综合审查ASCT在MS患者的早期和晚期不良影响.
- 强调预防和预防感染的预防策略的重要性.
- 强调二级自身免疫性疾病和生育问题的风险.
主要方法:
- 对MS的ASCT后早期和晚期并发症的文献综述.
- 分析感染类型,包括细菌,病毒和真菌.
- 检查非传染性并发症,二次自身免疫性疾病和内分泌病变.
主要成果:
- 早期的并发症包括感染 (细菌,病毒) 和非传染性问题 (粘膜炎,肝酶升高,囊炎).
- 晚期并发症包括二级自身免疫性疾病 (血液学和非血液学) 和内分泌病.
- 存在不孕不育和过早卵巢衰竭的重大风险,特别是在32岁以上的女性中.
结论:
- 对于MS的ASCT需要对早期和晚期不良事件进行警管理.
- 预防性和预防性治疗对于控制感染至关重要.
- 在ASCT之前,生殖咨询和生育保护对符合条件的患者来说是强制性的.
相关概念视频
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Tissue Transplantation
350
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
350


